Skip to main content

Table 3 List of graphene oxide and reduced graphene oxide composites and their bioimaging applications

From: Recent biomedical advancements in graphene oxide- and reduced graphene oxide-based nanocomposite nanocarriers

Composite

Imaging Type

Target Cell

Study Type

Additional Functions

Ref

ICG/CA-PPDN/rGO

Fluorescence quenching

Thermographic imaging

MDA-MB-231

In vitro/

In vivo

Phototherapy

[169]

(CA-BODIPY)-PPDN/rGO

Fluorescence quenching

MDCK

MDA-MB-231

In vitro

Drug Delivery

[161]

(CA–BODIPY)-PSMN/rGO

Fluorescence quenching

-

-

-

[180]

Gd-rGO

Optical coherence tomography

Fluorescence imaging

H1299

In vitro

Drug Delivery

[160]

rGO-Ru-PEG

Fluorescence imaging

A549

In vitro/

In vivo

Phototherapy

[170]

rGO/Au

Fluorescence imaging

Colo-205

MKN-45

In vitro

Biosensing

[35]

Amine‐GO

Sulfonate‐GO

Fluorescence imaging

NIH-3T3

HeLa

In vitro

-

[34]

GO@CP6  PyN

Photoacoustic imaging

U87MG

In vitro/

In vivo

-

[176]

FA-CS-GO

Photoacoustic imaging

MDA-MB-231

In vitro/

In vivo

Photothermal

[173]

GO-M75

Confocal Raman Microscopy

MDCK

In vitro

-

[179]

  1. Abbreviations: Au Gold, BODIPY Boron-dipyrromethene, CA Catechol, CP6  PyN Pillar[6]arene-based host–guest complex, PPDN Poly(ethylene glycol)-grafted poly(DMAEMA-co-NIPAAm), FA Folic Acid, Gd Gadolinium, GO Graphene oxide, ICG Indocyanine green, PEG Polyethylene glycol, PPDN PEG–g–poly (DMA–co–NIPAAm), PSMN Poly(sulfobetaine methacrylate-co-NIPAAm, rGO Reduced graphene oxide, Ru Ruthenium